dizzines zziness CHRONIC KIDNEY DISEASE WORLDWIDE 10 - 14% R$ 1.4 - - PowerPoint PPT Presentation

dizzines zziness chronic kidney disease worldwide
SMART_READER_LITE
LIVE PREVIEW

dizzines zziness CHRONIC KIDNEY DISEASE WORLDWIDE 10 - 14% R$ 1.4 - - PowerPoint PPT Presentation

CHRONIC KIDNEY DISEASE (CKD) Anemia Cardiovascular disease 2 a a 3 t times imes a w week 4 h hours s each quea easi sines ess Strict treatment dizzines zziness CHRONIC KIDNEY DISEASE WORLDWIDE 10 - 14% R$ 1.4 billion or US$ 570


slide-1
SLIDE 1
slide-2
SLIDE 2

CHRONIC KIDNEY DISEASE (CKD)

Cardiovascular disease Anemia

Strict treatment

4 h hours s each 2 a a 3 t times imes a w week

quea easi sines ess

dizzines zziness

slide-3
SLIDE 3

CHRONIC KIDNEY DISEASE WORLDWIDE R$ 1.4 billion

  • r

US$ 570 million

10 - 14%

slide-4
SLIDE 4

Equipment & Infrastructure

1

No easily handled devices

2

Sensitivity

3

WHY!? Where these expenses come from?!

slide-5
SLIDE 5

Equipment & Infrastructure

1

No easily handled devices

2

Sensitivity

3

slide-6
SLIDE 6

1 2 3

slide-7
SLIDE 7
slide-8
SLIDE 8

Detection Module

 Quorum

rum sen ensin ing g system

 Identifies Cys C

slide-9
SLIDE 9

Detection Module

The Cys C Biomarker

 More sensiti sitive e to small changes in the Glomerular Filtration Rate  - Concent centrat ation ion less s sucept eptib ible e to factor such as:

slide-10
SLIDE 10

Detection Module

How it works ?

  • 1. Cleavage of the Linker
  • 2. AIP (Auto inducer peptide) is released

and binds to the ComD receptor

  • 3. ComE phosphorilation

4.

lasR

3. 1. 2.

lasR

nM CatS CysC CatS CysC Ki 008 . ] : [ ] ][ [  

  • 4. LasR expression
slide-11
SLIDE 11

Diagnosis Module

How do we discriminate between increased and normal Cys C concentrations?

Increase creased levels Cys C Prognosi gnosis for CKD

We already have the means to...

production

slide-12
SLIDE 12

qteE (BBa_K1521000)

qteE

RBS SpoVG

 Pseudomonas aeruginosa

 Responsible for creating

expres ressi sion

  • n thres

resholds holds

 Const stitu tuti tive expression

  • Imunoblots. Espressing

qteE from the beggining

  • f the culture reduces

LasR accumulation.

  • Hamp

mpers LasR ability to promote downstream gene expression

SIEHNEL R, A unique regulator controls the activation threshold if quorum-regulated genes in Pseudomonas aeruginosa. Proc

  • cee

eedin ings s of the Nati tion

  • nal Academy

y of Sciences ces USA, 2010, 107(17):7916-7921.

slide-13
SLIDE 13

Diagnosis Module

Plac c promo moter er + qteE

  • Manipulate the expression rate

through IPTG G induction

  • Set the appropria

priate e thresh shol

  • ld

d for Cys discrimination

slide-14
SLIDE 14

Response Module

 Indu duced ced by by

 , practical mesurement reasons Control Device 1 Example from Interlab Study

slide-15
SLIDE 15

High High Levels Levels of

  • f

Cystatin Cystatin C LasR LasR

I N P U T

R E E S S P P O N N S S E E

GFP GFP

D I I A A G G N O O S S I I S S :

slide-16
SLIDE 16

High High Levels Levels of

  • f

Cystatin Cystatin C LasR LasR

I N P U T

R E E S S P P O N N S S E E

GFP GFP

D I I A A G G N O O S S I I S S :

slide-17
SLIDE 17

High High Levels Levels of

  • f

Cystatin Cystatin C LasR LasR

I N P U T

R E E S S P P O N N S S E E

GFP GFP

D I I A A G G N O O S S I I S S :

SICK

slide-18
SLIDE 18

Normal Levels Normal Levels of

  • f

Cystatin Cystatin C LasR LasR

I N P U T

R E E S S P P O N N S S E E

GFP GFP

D I I A A G G N O O S S I I S S :

slide-19
SLIDE 19

Normal Levels Normal Levels of

  • f

Cystatin Cystatin C LasR LasR

I N P U T

R E E S S P P O N N S S E E

GFP GFP

D I I A A G G N O O S S I I S S :

slide-20
SLIDE 20

Normal Levels Normal Levels of

  • f

Cystatin Cystatin C LasR LasR

I N P U T

R E E S S P P O N N S S E E

GFP GFP

D I I A A G G N O O S S I I S S : HEALTHY

slide-21
SLIDE 21

Important

 One crucial step for the feasibility of our project is the proper barrier er set et up

After construction

IPTG O.D.  Biodetector calibrat

bration ion

  • Standardized Cathepsin S

solution

  • Cys C concentration mimiking

normal blood levels

slide-22
SLIDE 22

Chassi

slide-23
SLIDE 23

Assembly Map

slide-24
SLIDE 24

Mathematical Modelling

slide-25
SLIDE 25

Chemical Kinectics

   

A  dt A d

 Ordinary differential equation  Evolution of the concentration in time

  • Initial conditions
  • Other parameter for dynamic strength

 Our chemical reactions are those that regulate:

  • Inducer/repressor binding/unbinding on promoter
  • Enzyme activity and its interaction with inhibitor
  • Reporter gene production (GFP)
slide-26
SLIDE 26

The CAOS !!!

slide-27
SLIDE 27

 ComE limit concentration experiments (Imperial College Team 2010)  Tokyo team Plac IPTG induction equation

slide-28
SLIDE 28

 Considering the formation of a LasR-QteE complex

slide-29
SLIDE 29
slide-30
SLIDE 30

Creation of the Expression Barrier

lasR

gfp

PlasR PVeg Result Control

slide-31
SLIDE 31

Creation of the Expression Barrier

lasR

gfp

PlasR PVeg

qteE

PVeg Control Result

slide-32
SLIDE 32

Next steps

 Complementary experiments with extra circuits:

  • Objective: Characterize the LasR:QteE interaction (ratio and

induced response)

gfp

PlasR

lasR

Plac

qteE

Plac

lasR

Pveg

qteE

Pveg

slide-33
SLIDE 33

In a near Future

 After better characterization of the qteE threshold property, it can be used for:

  • Creation of mul

ultiple iple st standar ndardi dize zed d thres eshold

  • lds for more

qua uantit itati tive biological system

  • Coor
  • rdina

dinati tion

  • n of cellular pathways; conc

ncentrat entration ion trigge gers

slide-34
SLIDE 34
slide-35
SLIDE 35

Microfluidics

  • 1. Easy

sy to Use

  • 2. Low

Sample Usage

  • 3. More

accurat rate

and reproducibl ducible 4.

. Less ss

dependent

  • n costly

stly

detection

instruments

  • 5. Chea

eaper per devices

slide-36
SLIDE 36

Transform complex biodetection system into user-friendly devices

slide-37
SLIDE 37

1.

  • 1. Spores
  • 2. Activation medium +

IPTG

  • 3. Standardized

Cathepsin S Solution

  • 4. Sanitation solution

Reaction Chamber

slide-38
SLIDE 38

1.

  • 1. Spores
  • 2. Activation medium +

IPTG

  • 3. Standardized

Cathepsin S Solution

  • 4. Sanitation solution

Reaction Chamber

slide-39
SLIDE 39

1.

  • 1. Spores
  • 2. Activation medium +

IPTG

  • 3. Standardized

Cathepsin S Solution

  • 4. Sanitation solution

Reaction Chamber

slide-40
SLIDE 40

1.

  • 1. Spores
  • 2. Activation medium +

IPTG

  • 3. Standardized

Cathepsin S Solution

  • 4. Sanitation solution

Reaction Chamber

slide-41
SLIDE 41

1.

  • 1. Spores
  • 2. Activation medium +

IPTG

  • 3. Standardized

Cathepsin S Solution

  • 4. Sanitation solution

Reaction Chamber

slide-42
SLIDE 42

1.

  • 1. Spores
  • 2. Activation medium +

IPTG

  • 3. Standardized

Cathepsin S Solution

  • 4. Sanitation solution

Reaction Chamber

How to use it

1) Press buttons 1 and 2 (spores activation) 2) Add blood sample in the reaction chamber 3) Seal reaction chamber with extra membrane 4) Press 3 5) Repeatedly press the membrane to mix the reaction chamber content 6) Wait for diagnosis 7) Interpretate result 8) Press 4 9) Ready to discard

slide-43
SLIDE 43
slide-44
SLIDE 44

The brazilian Jamboree

Brasil-SP team

slide-45
SLIDE 45

Policy and Practices

slide-46
SLIDE 46

Policy and Practices

Scient ntif ific ic Development elopment Social al Developmen

  • pment
slide-47
SLIDE 47

It’s Time !

slide-48
SLIDE 48

Thank you all !!

Sponsors